• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Parenteral grade, vegetable-derived Cholesterol (FDA DMF 29599)

7 September 2016  •  Author: Wilshire Technologies

The virtues of vegetal- vs. animal-derived actives and excipients are well-known and need no elaboration. Wilshire Technologies has been a leader in offering cGMP-compliant, animal-origin-free (AOF) vegetal replacements for animal-derived products.

PhytoChol®, our fully EP-, USP-, cGMP-compliant, vegetal-derived Cholesterol (FDA DMF 27020) was introduced nearly a decade ago and has since gained broad acceptance throughout the pharma and biopharma industries. Today, Wilshire Technologies is the only reliable source of gram and bulk (Kg, MT), cGMP |non-cGMP, AOF, vegetal-derived Cholesterol, and the only one to offer consumer-verifiable proof of its unadulterated plant origin.

Previously unavailable, but sorely needed, has been a vegetal-derived parenteral-grade Cholesterol. Wilshire Technologies is now pleased to introduce PhytoChol® puriss (FDA DMF 29599), the first vegetal-derived Cholesterol for parenteral use.

To learn more about this advancement or the arc of other vegetal-derived, parenteral ingredients offered by WTI, click here . . . or visit www.wilshiretechnologies.com

Europe
+33.(0)977.218.403
infoeurope@wilshiretechnologies.com

Visit us at CPhI Worldwide 2016 in Barcelona, Stand 3M65; click here.

Leave a reply

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +